Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Garufi

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Digestive Diseases and Sciences|July 1, 1991
Hepatocarcinoma in cirrhosis. Is antithrombin III a neoplastic marker?A Grieco, V De Stefano, A Cassano, et al.
British Journal of Cancer|November 1, 1992
Immunological effects of alternative weekly interferon-alpha-2b and low dose interleukin-2 in patients with cancerB Fiorentino, P Di Stefano, C Giuliani, et al.
Lupus|July 14, 2019
Lupus anticoagulant remission after gluten-free diet in a coeliac pregnant womanS Tabacco, C Garufi, A Giannini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Single-agent oxaliplatin in pretreated advanced breast cancer patients: a phase II studyC Garufi, C Nisticò, S Brienza, et al.
Anticancer Research|February 24, 2001
Phase II trial of chronomodulated infusion of 5-fluorouracil and folinic acid in metastatic colorectal cancerH Cure, V Chevalier, D Pezet, et al.
Tumori|June 30, 1990
Role of immunoscintigraphy in clinical assessment of gastrointestinal tumorsC Barone, E Ricevuto, C Garufi, et al.
British Journal of Cancer|April 16, 2002
Circadian optimisation of irinotecan and oxaliplatin efficacy in mice with Glasgow osteosarcomaT G Granda, R-M D'Attino, E Filipski, et al.
Oncology|January 1, 1991
Association of epirubicin, etoposide and cisplatin in gastric cancer. A phase II studyC Barone, A Cassano, A Astone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Phase II study of epirubicin and vinorelbine with granulocyte colony-stimulating factor: a high-activity, dose-dense weekly regimen for advanced breast cancerC Nisticò, C Garufi, S Barni, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Phase II study of mitomycin C, etoposide and vindesine in metastatic stage IV non-small-cell lung cancerC Gridelli, R Pepe, S Palmeri, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Digestive Diseases and Sciences|July 1, 1991
Hepatocarcinoma in cirrhosis. Is antithrombin III a neoplastic marker?A Grieco, V De Stefano, A Cassano, et al.
British Journal of Cancer|November 1, 1992
Immunological effects of alternative weekly interferon-alpha-2b and low dose interleukin-2 in patients with cancerB Fiorentino, P Di Stefano, C Giuliani, et al.
Lupus|July 14, 2019
Lupus anticoagulant remission after gluten-free diet in a coeliac pregnant womanS Tabacco, C Garufi, A Giannini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Single-agent oxaliplatin in pretreated advanced breast cancer patients: a phase II studyC Garufi, C Nisticò, S Brienza, et al.
Anticancer Research|February 24, 2001
Phase II trial of chronomodulated infusion of 5-fluorouracil and folinic acid in metastatic colorectal cancerH Cure, V Chevalier, D Pezet, et al.
Tumori|June 30, 1990
Role of immunoscintigraphy in clinical assessment of gastrointestinal tumorsC Barone, E Ricevuto, C Garufi, et al.
British Journal of Cancer|April 16, 2002
Circadian optimisation of irinotecan and oxaliplatin efficacy in mice with Glasgow osteosarcomaT G Granda, R-M D'Attino, E Filipski, et al.
Oncology|January 1, 1991
Association of epirubicin, etoposide and cisplatin in gastric cancer. A phase II studyC Barone, A Cassano, A Astone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Phase II study of epirubicin and vinorelbine with granulocyte colony-stimulating factor: a high-activity, dose-dense weekly regimen for advanced breast cancerC Nisticò, C Garufi, S Barni, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Phase II study of mitomycin C, etoposide and vindesine in metastatic stage IV non-small-cell lung cancerC Gridelli, R Pepe, S Palmeri, et al.
Pageof 6